vs
Axsome Therapeutics, Inc.（AXSM）与WSFS FINANCIAL CORP（WSFS）财务数据对比。点击上方公司名可切换其他公司
WSFS FINANCIAL CORP的季度营收约是Axsome Therapeutics, Inc.的1.4倍（$275.3M vs $196.0M），WSFS FINANCIAL CORP净利率更高（31.5% vs -14.6%，领先46.1%），Axsome Therapeutics, Inc.同比增速更快（65.0% vs 7.5%），过去两年Axsome Therapeutics, Inc.的营收复合增速更高（61.7% vs 1.7%）
Jazz Pharmaceuticals是一家全球生物制药企业，专注于肿瘤学与神经科学领域的药物研发及商业化。公司2003年在美国加利福尼亚州成立，目前总部位于爱尔兰都柏林，业务覆盖全球多个核心市场。
WSFS金融集团是一家金融服务企业，核心子公司WSFS银行是总部位于特拉华州及大特拉华谷地区规模最大、经营历史最久的本地管理银行与财富管理机构。集团共运营115个网点，其中88个为银行网点，分布在宾夕法尼亚、特拉华、新泽西、佛罗里达、弗吉尼亚、内华达六州，提供全面金融服务。
AXSM vs WSFS — 直观对比
营收规模更大
WSFS
是对方的1.4倍
$196.0M
营收增速更快
AXSM
高出57.5%
7.5%
净利率更高
WSFS
高出46.1%
-14.6%
两年增速更快
AXSM
近两年复合增速
1.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $196.0M | $275.3M |
| 净利润 | $-28.6M | $86.8M |
| 毛利率 | — | — |
| 营业利润率 | -13.8% | — |
| 净利率 | -14.6% | 31.5% |
| 营收同比 | 65.0% | 7.5% |
| 净利润同比 | 61.9% | 31.7% |
| 每股收益（稀释后） | $-0.55 | $1.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXSMWSFS
| Q1 26 | — | $275.3M | ||
| Q4 25 | $196.0M | $271.9M | ||
| Q3 25 | $171.0M | $270.5M | ||
| Q2 25 | $150.0M | $267.5M | ||
| Q1 25 | $121.5M | $256.1M | ||
| Q4 24 | $118.8M | $261.5M | ||
| Q3 24 | $104.8M | $267.7M | ||
| Q2 24 | $87.2M | $266.0M |
净利润AXSMWSFS
| Q1 26 | — | $86.8M | ||
| Q4 25 | $-28.6M | $72.7M | ||
| Q3 25 | $-47.2M | $76.4M | ||
| Q2 25 | $-48.0M | $72.3M | ||
| Q1 25 | $-59.4M | $65.9M | ||
| Q4 24 | $-74.9M | $64.2M | ||
| Q3 24 | $-64.6M | $64.4M | ||
| Q2 24 | $-79.3M | $69.3M |
营业利润率AXSMWSFS
| Q1 26 | — | — | ||
| Q4 25 | -13.8% | 35.8% | ||
| Q3 25 | -27.0% | 37.3% | ||
| Q2 25 | -24.5% | 35.7% | ||
| Q1 25 | -46.9% | 34.0% | ||
| Q4 24 | -61.1% | 32.3% | ||
| Q3 24 | -59.8% | 31.9% | ||
| Q2 24 | -89.5% | 34.0% |
净利率AXSMWSFS
| Q1 26 | — | 31.5% | ||
| Q4 25 | -14.6% | 26.7% | ||
| Q3 25 | -27.6% | 28.3% | ||
| Q2 25 | -32.0% | 27.0% | ||
| Q1 25 | -48.9% | 25.7% | ||
| Q4 24 | -63.1% | 24.6% | ||
| Q3 24 | -61.7% | 24.1% | ||
| Q2 24 | -91.0% | 26.0% |
每股收益（稀释后）AXSMWSFS
| Q1 26 | — | $1.64 | ||
| Q4 25 | $-0.55 | $1.33 | ||
| Q3 25 | $-0.94 | $1.37 | ||
| Q2 25 | $-0.97 | $1.27 | ||
| Q1 25 | $-1.22 | $1.12 | ||
| Q4 24 | $-1.54 | $1.08 | ||
| Q3 24 | $-1.34 | $1.08 | ||
| Q2 24 | $-1.67 | $1.16 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $322.9M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $88.3M | $2.7B |
| 总资产 | $689.8M | $22.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AXSMWSFS
| Q1 26 | — | — | ||
| Q4 25 | $322.9M | $1.7B | ||
| Q3 25 | $325.3M | — | ||
| Q2 25 | $303.0M | — | ||
| Q1 25 | $300.9M | — | ||
| Q4 24 | $315.4M | $1.2B | ||
| Q3 24 | $327.3M | — | ||
| Q2 24 | $315.7M | — |
股东权益AXSMWSFS
| Q1 26 | — | $2.7B | ||
| Q4 25 | $88.3M | $2.7B | ||
| Q3 25 | $73.7M | $2.8B | ||
| Q2 25 | $73.1M | $2.7B | ||
| Q1 25 | $53.2M | $2.7B | ||
| Q4 24 | $57.0M | $2.6B | ||
| Q3 24 | $92.9M | $2.7B | ||
| Q2 24 | $102.9M | $2.5B |
总资产AXSMWSFS
| Q1 26 | — | $22.1B | ||
| Q4 25 | $689.8M | $21.3B | ||
| Q3 25 | $669.3M | $20.8B | ||
| Q2 25 | $639.8M | $20.8B | ||
| Q1 25 | $596.7M | $20.5B | ||
| Q4 24 | $568.5M | $20.8B | ||
| Q3 24 | $561.5M | $20.9B | ||
| Q2 24 | $548.2M | $20.7B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-18.7M | — |
| 自由现金流经营现金流 - 资本支出 | $-18.7M | — |
| 自由现金流率自由现金流/营收 | -9.6% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-93.9M | — |
8季度趋势，按日历期对齐
经营现金流AXSMWSFS
| Q1 26 | — | — | ||
| Q4 25 | $-18.7M | $220.0M | ||
| Q3 25 | $1.0M | $121.5M | ||
| Q2 25 | $-32.4M | $37.2M | ||
| Q1 25 | $-43.4M | $8.7M | ||
| Q4 24 | $-26.2M | $219.9M | ||
| Q3 24 | $-18.6M | $3.1M | ||
| Q2 24 | $-30.1M | $44.8M |
自由现金流AXSMWSFS
| Q1 26 | — | — | ||
| Q4 25 | $-18.7M | $213.6M | ||
| Q3 25 | $988.0K | $120.3M | ||
| Q2 25 | $-32.4M | $35.2M | ||
| Q1 25 | $-43.7M | $6.3M | ||
| Q4 24 | $-26.2M | $205.6M | ||
| Q3 24 | $-18.7M | $-489.0K | ||
| Q2 24 | $-30.2M | $42.1M |
自由现金流率AXSMWSFS
| Q1 26 | — | — | ||
| Q4 25 | -9.6% | 78.6% | ||
| Q3 25 | 0.6% | 44.5% | ||
| Q2 25 | -21.6% | 13.2% | ||
| Q1 25 | -36.0% | 2.5% | ||
| Q4 24 | -22.1% | 78.6% | ||
| Q3 24 | -17.9% | -0.2% | ||
| Q2 24 | -34.6% | 15.8% |
资本支出强度AXSMWSFS
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 2.3% | ||
| Q3 25 | 0.0% | 0.5% | ||
| Q2 25 | 0.0% | 0.7% | ||
| Q1 25 | 0.3% | 0.9% | ||
| Q4 24 | 0.0% | 5.5% | ||
| Q3 24 | 0.1% | 1.4% | ||
| Q2 24 | 0.1% | 1.0% |
现金转化率AXSMWSFS
| Q1 26 | — | — | ||
| Q4 25 | — | 3.03× | ||
| Q3 25 | — | 1.59× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 3.43× | ||
| Q3 24 | — | 0.05× | ||
| Q2 24 | — | 0.65× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
